Interleukin-1β does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 341-344

  Zeise, M L ^a   Espinoza, J ^a   Morales, P ^a   Nalli, A ^a  

^a UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Hippocampus; Interleukin 1 ; Intracellular recording; Pyramidal cell granule cell; Slice preparation; Synaptic inhibition

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 1;

ANIMAL CELL; ARTICLE; BRAIN OXYGEN CONSUMPTION; DENTATE GYRUS; DRUG EFFECT; GRANULE CELL; HIPPOCAMPUS; INTRACELLULAR RECORDING; LONG TERM POTENTIATION; MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR DENSITY; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; ANIMAL; CYTOLOGY; IN VITRO STUDY; MALE; NERVE CELL; NERVE CELL INHIBITION; PATCH CLAMP; SPRAGUE DAWLEY RAT;

ANIMALS; DENTATE GYRUS; INTERLEUKIN-1; MALE; NEURAL INHIBITION; NEURONS; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

EID: 0030613694     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00787-7     Document Type: Article

References (15)

1. Araujo D.M., Lapchak P.A. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience. 61:1994;745-754.
2. Ban E.M. Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods. 5:1994;31-40.
3. Bellinger F.P., Madamba S., Siggins G.R. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628:1993;227-234.
4. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203:1996;17-20.
5. DeKosky S.T., Goss J.R., Miller P.D., Styren S.D., Kochanek P.M., Marion D. Upregulation of nerve growth factor following cortical trauma. Exp. Neurol. 130:1994;173-177.
6. Dinarello C.A. Interleukin-1 and interleukin antagonism. Blood. 77:1991;1627-1652.
7. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res. - Mol. Brain Res. 30:1995;125-130.
8. Katsuki H., Nakai S., Hirai Y., Akaji Ken-Ichi, Kiso Y., Satoh M. Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181:1990;323-326.
9. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. - Mol. Brain Res. 27:1994;157-162.
10. Lechan R.M., Toni R., Clark B.D., Cannon J.G., Shaw A.R., Dinarello C.A., Reichlin S. Immunoreactive interleukin-1β localization in the rat forebrain. Brain Res. 514:1990;135-140.
11. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex. I. Clinical features. Ann. Neurol. 19:1986;517-524.
12. Parnet P., Amindari S., Wu C., Brunke-Reese D., Goujon E., Weyhenmeyer J.A., Dantzer R., Kelley K.W. Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res. - Mol. Brain Res. 27:1994;63-70.
13. 2+ channel currents in hippocampal neurons through protein kinase C. Eur. J. Pharmacol. 266:1994;1-10.
14. Szaflarski J., Burtrum D., Silverstein F.S. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke. 26:1995;1093-1100.
15. Zeise M.L., Madamba S., Siggins G.R. Interleukin-1β increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro. Regul. Pept. 39:1992;1-7.